Mary N. Dillon
Mary N. Dillon's purchase track record
Mary N. Dillon has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/2/2026 | KKR | $2.02M | +5.1% | +21.4% | +11.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KKR expands solar portfolio amid mixed analyst views on valuation. KKR added $1.2 billion in solar capacity to its U.S. renewables venture, continuing its push into clean energy infrastructure. The move comes as analysts maintain a positive outlook on the firm, though some question whether the stock is overvalued following a significant three-year run. The company's focus on security and digital infrastructure spending remains a key theme in its investment strategy.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Starbucks Faces Growing Problem Despite Returning Customers. Starbucks is dealing with a growing problem even as customers return, according to recent reports. The stock has risen 15% year‑to‑date, prompting questions about further upside. Jim Cramer noted that Starbucks can rise on its own, highlighting the company's resilience.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ulta Beauty faces caution on softer 2026 guidance. Ulta Beauty issued softer guidance for the second half of 2026, prompting analysts to advise caution despite the current 'lipstick effect' in consumer spending. While the company is being watched as a retail pick for the upcoming holiday season, the revised outlook suggests potential headwinds ahead. The stock remains near its 52-week high, with an RSI of 74.8 indicating strong recent momentum.
Transaction History
| AAL | ▲ Buy | Grant | 11,177 | $0 | 6/10/2026 | View on chart |
| AAL | ▲ Buy | Grant | 3,031 | $0 | 3/24/2026 | View on chart |
| KKR | ▲ Buy | Open Market | 22,225 | $2.0M | 3/2/2026 | View on chart |
| KKR | ▲ Buy | Grant | 1,605 | $0 | 12/11/2025 | View on chart |
| KKR | ▲ Buy | Grant | 1,238 | $0 | 12/12/2024 | View on chart |
| KKR | ▲ Buy | Grant | 3,029 | $0 | 10/2/2023 | View on chart |
| KKR | ▲ Buy | Grant | 4,134 | $0 | 10/20/2022 | View on chart |
| SBUX | ▲ Buy | Grant | 3,775 | $0 | 3/16/2022 | View on chart |
| ULTA | ▼ Sell | Tax Withholding | 1,890 | $702K | 3/15/2022 | View on chart |
| KKR | ▲ Buy | Grant | 2,479 | $0 | 12/9/2021 | View on chart |
| ULTA | ▼ Sell | Open Market | 1,577 | $652K | 12/8/2021 | View on chart |
| ULTA | ▲ Buy | Option Exercise | 50,000 | $8.2M | 12/8/2021 | View on chart |
| ULTA | ▼ Sell | Open Market | 4,481 | $1.8M | 12/8/2021 | View on chart |
| ULTA | ▼ Sell | Open Market | 29,408 | $12.1M | 12/8/2021 | View on chart |
| ULTA | ▼ Sell | Open Market | 7,193 | $3.0M | 12/8/2021 | View on chart |
| ULTA | ▼ Sell | Open Market | 2,246 | $926K | 12/8/2021 | View on chart |
| ULTA | ▼ Sell | Open Market | 5,095 | $2.1M | 12/8/2021 | View on chart |
| ULTA | ▲ Buy | Grant | 27,707 | $0 | 9/30/2021 | View on chart |
| ULTA | ▼ Sell | Tax Withholding | 12,275 | $4.4M | 9/30/2021 | View on chart |
| ULTA | ▼ Sell | Tax Withholding | 10,844 | $3.9M | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Analysts Lower AAL Fair Value Amid Rising Fuel Cost Concerns
Analysts have lowered American Airlines’ fair value after reexamining fuel cost assumptions. The recent Goldman Sachs cut to an $11 target reflects the same concern. New regulatory pressure to carry epinephrine on all flights could add to operating costs, while broader airline earnings reports from Delta give context to the sector’s mixed outlook.
Analysts Lower AAL Fair Value Amid Rising Fuel Cost Concerns. Analysts have lowered American Airlines’ fair value after reexamining fuel cost assumptions. The recent Goldman Sachs cut to an $11 target reflects the same concern. New regulatory pressure to carry epinephrine on all flights could add to operating costs, while broader airline earnings reports from Delta give context to the sector’s mixed outlook.